BRIEF-HBM Holdings Says Jury Returns Verdict In Favor Of Harbour Antibodies Against Amgen IN U.S. Patent Case

June 15 (Reuters) – Hbm Holdings Ltd: * JURY VERDICT IN U.S. PATENT INFRINGEMENT LITIGATION * JURY RETURNS VERDICT IN FAVOR OF HARBOUR ANTIBODIES AGAINST AMGEN IN U.S. PATENT CASE * HARBOUR ANTIBODIES

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)